Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02134119 · ClinicalTrials.gov registry record · NA

Echinacea-based Supplement Does Not Improve Markers of Performance in Athletes

A NA study, sponsored by University of Georgia.

Completed
Registry status
NA
Development phase
45
Enrollment target

NCT02134119 is a NA study that has completed, run by University of Georgia. The registered enrollment target is 45 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02134119, a NA study, has completed, sponsored by University of Georgia.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target

Study Summary

The purpose of this study was three-fold. We wanted to (1) determine if supplementation with an echinacea-based dietary supplement (ECH) would increase several blood parameters that could affect oxygen carrying capacity in the body, (2) determine if ECH would increase VO2max in trained endurance athletes, and (3) examine the effectiveness of two different doses of the ECH on all outcome variables. We hypothesized that supplementation with ECH would increase oxygen carrying capacity (as measured by RBCs, EPO, ferritin, hemoglobin (Hb), and hematocrit (Hct) levels), improve VO2max, and that the maximum dose would be most effective at increasing these outcomes.

Interventions

  • DRUG Placebo
  • DIETARY_SUPPLEMENT Echinacea-based dietary supplement

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2012-01
Est. Completion 2013-07
Phase NA

Sponsor

University of Georgia

59 total trials

What the Registry Record Tells You About NCT02134119

The ClinicalTrials.gov registry entry for NCT02134119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02134119 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02134119 about?

NCT02134119 is a clinical study titled "Echinacea-based Supplement Does Not Improve Markers of Performance in Athletes". The purpose of this study was three-fold. We wanted to (1) determine if supplementation with an echinacea-based dietary supplement (ECH) would increase several blood parameters that could affect oxygen carrying capacity in the body, (2) determine if ECH would increase VO2max in trained endurance ath...

What is the current status of trial NCT02134119?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2012-01. Estimated completion is 2013-07.

What interventions are being tested in trial NCT02134119?

The interventions under investigation include: Placebo (DRUG), Echinacea-based dietary supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02134119?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.